The following table provides information about disaggregated revenue by product mix for the three and nine months ended September 30, 2019 and 2018: (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Product Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 23,719,741	$ 3,473,535	$ 33,745,257	$ 11,009,937
Prescription Vitamins [Member]
Product Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	2,550,330	3,261,459	7,309,174	10,797,861
Imvexxy
Product Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	4,772,354	212,076	9,904,744	$ 212,076
BIJUVA [Member]
Product Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	490,705		624,987
ANNOVERA [Member]
Product Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	399,952		399,952
License and Service [Member]
Product Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 15,506,400	$ 0	$ 15,506,400